These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18344629)

  • 1. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
    Takai S; Jin D; Ikeda H; Sakonjo H; Miyazaki M
    Hypertens Res; 2009 Oct; 32(10):853-60. PubMed ID: 19662023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
    Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
    Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
    Khan AH; Imig JD
    Am J Hypertens; 2011 Jul; 24(7):816-21. PubMed ID: 21415842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
    Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Waki H; Maeda M; Ogawa H; Kim-Mitsuyama S
    Atherosclerosis; 2014 Sep; 236(1):101-7. PubMed ID: 25016364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic production of peroxynitrite in the vascular wall impairs vasorelaxation function in SHR/NDmcr-cp rats, an animal model of metabolic syndrome.
    Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    J Pharmacol Sci; 2009 Apr; 109(4):556-64. PubMed ID: 19346675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin inhibition stimulates PPARgamma and the release of visfatin.
    Storka A; Vojtassakova E; Mueller M; Kapiotis S; Haider DG; Jungbauer A; Wolzt M
    Eur J Clin Invest; 2008 Nov; 38(11):820-6. PubMed ID: 19021699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
    Takai S; Jin D; Aritomi S; Niinuma K; Miyazaki M
    Hypertens Res; 2013 Apr; 36(4):342-8. PubMed ID: 23190689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained antihypertensive activity of telmisartan compared with valsartan.
    Lacourcière Y; Krzesinski JM; White WB; Davidai G; Schumacher H
    Blood Press Monit; 2004 Aug; 9(4):203-10. PubMed ID: 15311147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
    Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
    J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    Toba H; Tojo C; Wang J; Noda K; Kobara M; Nakata T
    Eur J Pharmacol; 2012 Jun; 685(1-3):91-8. PubMed ID: 22314223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
    Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
    Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of valsartan and benazeprilat in salt-loaded stroke-prone spontaneously hypertensive rats.
    Webb RL; Barclay BW; Navarrete AE; Wosu NJ; Sahota P
    Clin Exp Hypertens; 1998 Oct; 20(7):775-93. PubMed ID: 9764721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.
    Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Feb; 51(2):296-301. PubMed ID: 18158350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
    Xu L; Liu Y
    Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.